From steering billion-dollar diagnostics businesses to reshaping how labs operate across continents, Colin Hill’s career has been defined by one thing: leading transformation at scale.

With more than 30 years at the helm of global organisations, Colin has turned cutting-edge science into healthcare breakthroughs, driving innovation pipelines, executing major M&A deals, and building teams that deliver results from concept to commercialisation. He’s held senior leadership roles at BioMérieux, Mars Science & Diagnostics, Thermo Fisher Scientific, and Asuragen, guiding operations across Europe, the Americas, and emerging markets. Today, as a non-Executive Director at BBI Solutions (a Novo Holdings company), he helps shape the critical raw materials and reagents that power diagnostics worldwide.

But Colin isn’t just a strategist, he’s a change agent. Known for challenging the status quo, he has redefined operating models, navigated high-stakes transitions, and inspired teams to reach new heights of performance and innovation. Colleagues describe him as a leader with rare range: able to zoom out to chart long-term vision, then dive into the details to unlock executional excellence.

At Impactful Innovation, Colin will explore the future of diagnostics and what it takes to lead bold change in an industry where precision, speed, and global scale can mean the difference between life and death..